Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study
Molecules · 04.07.2024 · 29 (13) · 3186
DOI: 10.3390/molecules29133186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 04.07.2024. Verfasst von Wafaa A Ewes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Proto-Oncogene Proteins B-raf, Protein Kinase Inhibitors, Benzothiazoles. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia., King Saud University, Riyadh, Saudi Arabia.
Abstract (Originalsprache)
Cancer remains a leading cause of death worldwide, often resulting from uncontrolled growth in various organs. Protein kinase inhibitors represent an important class of targeted cancer therapies. Recently, the kinases BRAF and VEGFR-2 have shown synergistic effects on tumor progression. Seeking to develop dual BRAF/VEGFR-2 inhibitors, we synthesized 18 amino-benzothiazole derivatives with structural similarities to reported dual inhibitors. Four compounds—4a, 4f, 4l, and 4r—demonstrated remarkable cytotoxicity, with IC50 values ranging from 3.58 to 15.36 μM, against three cancer cell lines. Furthermore, these compounds showed IC50 values of 38.77–66.22 μM in the case of a normal cell line, which was significantly safer than the reference, sorafenib. Subsequent investigation revealed that compound 4f exhibited the capacity to inhibit the BRAF and VEGFR-2 enzymes, with IC50 values similar to sorafenib (0.071 and 0.194 μM, respectively). Moreover, compound 4f caused G2-M- and S-phase cycle arrest. Molecular modeling demonstrated binding patterns compatible with inhibition for both targets, where 4f exerted the critical interactions in the BRAF site and interacted in the VEGFR-2 site in a manner akin to sorafenib, demonstrating affinity similar to dabrafenib.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
- Department of Anatomy, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.
ORCID-Profile: Wafaa A Ewes, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed A El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Förderung
- King Saud University, Riyadh, Saudi Arabia.
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Ewes, W. A., Tawfik, S. S., Almatary, A. M., Ahmad Bhat, M., El-Shafey, H. W., Mohamed, A. A. B., Haikal, A., El-Magd, M. A., Elgazar, A. A., Balaha, M., & Hamdi, A. (2024). Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules, 29(13), 3186. https://doi.org/10.3390/molecules29133186
Vancouver
Ewes WA, Tawfik SS, Almatary AM, Ahmad Bhat M, El-Shafey HW, Mohamed AAB, et al. Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules. 2024;29(13):3186. doi:10.3390/molecules29133186
BibTeX
@article{Ewes2024,
author = {Ewes, Wafaa A and Tawfik, Samar S and Almatary, Aya M and Ahmad Bhat, Mashooq and El-Shafey, Hamed W and Mohamed, Ahmed A B and Haikal, Abdullah and El-Magd, Mohammed A and Elgazar, Abdullah A and Balaha, Marwa and Hamdi, Abdelrahman},
title = {Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study},
journal = {Molecules},
year = {2024},
volume = {29},
number = {13},
pages = {3186},
doi = {10.3390/molecules29133186}
}
EUVIMED